Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

12
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
12

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of survival outcomes for people with HR+/HER2- metastatic breast cancer who received palbociclib, ribociclib, or abemaciclib with an aromatase inhibitor: a plain language summary.

Future oncology (London, England)·2026
Same author

Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort.

JNCI cancer spectrum·2026
Same author

Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025.

Cancer·2026
Same author

Survival and Treatment Patterns in Stage III Inflammatory and Noninflammatory Breast Cancer.

JAMA network open·2026
Same author

Real-world progression-free survival 2 (PFS2) and tumor response of CDK4/6 inhibitors plus an aromatase inhibitor in patients with HR+/HER2- metastatic breast cancer in US routine clinical practice.

Breast (Edinburgh, Scotland)·2026
Same author

The Plastic Surgery In-Service Examination: A Scoping Review.

Annals of plastic surgery·2026

Related Experiment Video

Updated: Jul 15, 2025

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.7K

Preoperative Risk Factors for Lymphedema in Inflammatory Breast Cancer.

Libby R Copeland-Halperin1, Colby J Hyland2, Goutam K Gadiraju3

  • 1Department of Surgery, Northwell Health, New York, New York.

Journal of Reconstructive Microsurgery
|September 26, 2023
PubMed
Summary
This summary is machine-generated.

Obesity and non-white race are key preoperative risk factors for developing lymphedema after inflammatory breast cancer treatment. Identifying these factors can help guide prophylactic lymphatic bypass (LYMPHA) decisions for high-risk patients.

More Related Videos

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
05:44

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Published on: January 12, 2017

10.1K
A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
09:50

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

8.1K

Related Experiment Videos

Last Updated: Jul 15, 2025

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.7K
Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
05:44

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Published on: January 12, 2017

10.1K
A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
09:50

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

8.1K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Lymphedema Research

Background:

  • Lymphedema affects up to 47% of breast cancer patients, necessitating preventive strategies like prophylactic lymphatic bypass (LYMPHA).
  • Preoperative identification of lymphedema risk factors is crucial for guiding LYMPHA decisions, as intraoperative and postoperative factors are often unknown at the time of decision-making.
  • Inflammatory breast cancer (IBC) patients represent a high-risk population requiring specific risk factor analysis.

Purpose of the Study:

  • To identify preoperative risk factors for lymphedema development in patients with inflammatory breast cancer (IBC).
  • To inform the clinical decision-making process regarding the prophylactic lymphatic microsurgical preventive healing approach (LYMPHA) in high-risk breast cancer populations.

Main Methods:

  • Retrospective review of an institutional IBC program database.
  • Multivariable logistic regression analysis to identify preoperative risk factors.
  • Controlled for lymph node dissection details, residual disease, and adjuvant chemotherapy requirements.

Main Results:

  • Obesity (BMI > 30) was associated with a 2.7-fold increased odds of lymphedema (OR: 2.7, CI: 1.2-6.4, p=0.02).
  • Non-white race was associated with a 4.5-fold increased odds of lymphedema (OR: 4.5, CI: 1.2-23, p=0.04).
  • 47% of all 356 patients with IBC developed lymphedema.

Conclusions:

  • Obesity and non-white race are significant preoperative risk factors for lymphedema in IBC patients.
  • Given the high prevalence of lymphedema in IBC, LYMPHA should be strongly considered for all patients.
  • Further prospective studies are warranted to investigate potential racial disparities in lymphedema development.